Loading...
Please wait, while we are loading the content...
Similar Documents
Oral Abstract Session: Predicting outcome in valvular heart disease * Thursday 8 December 2011, 08:30-10:00 * Location: Kaposvar
| Content Provider | Semantic Scholar |
|---|---|
| Author | Heyning, Caroline M. Van De Magne, Julien Mahjoub, Haïfa Pibarot, Philippe Connor, Kim O’ Pirlet, Charles Pierard, L. Lancellotti, Patrizio Mohty, Dania Deltreuil, Mathieu Tanguy, Benedicte Cassat, Claude Dumesnil, Jean Gaston Virot, Patrice Zilberszac, Robert Gabriel, Harald Maurer, Gerald Rosenhek, Raphael Mizarienė, Vaida Žaliaduonytė-Pekšienė, Diana Janėnaitė, Jūratė Marcinkeviciene, J. Vaišvila, Tautvydas Jankauskienė, Edita Ereminienė, Eglė Vaškelytė, Jolanta Justina Jurkevicius, Renaldas Ewe, See Hooi Haeck, Marlieke L. A. Witkowski, Tomasz Auger, Dominique Leong, Darryl P. Abate, Elena Ajmone, N. Bax, Jeroen J. Delgado, Victoria |
| Copyright Year | 2011 |
| Abstract | Introduction: In degenerative mitral regurgitation (MR), brain natriuretic peptide (BNP) is a surrogate biomarker of the consequences of MR on the left ventricle (LV) and left atrium (LA). LV global longitudinal strain (GLS), quantified by 2-D speckle-tracking imaging (2DSt) improved the detection of subclinical LV dysfunction. We aimed at evaluating the impact of BNP on outcome and its relationship with GLS, in asymptomatic patients with degenerative MR. Methods and results: Comprehensive transthoracic echocardiography including 2DSt quantification was performed in 135 consecutive asymptomatic patients (60+14 years, 55% of male) with moderate to severe degenerative MR (61% with severe MR) and preserved LV function. Simultaneously, blood sample was drawn and plasma BNP level was measured. BNP widely varied over patients (mean=61+70, range: 5-439, median= 41pg/ml) and was correlated with age (r=0.28, p=0.009), indexed LV endsystolic diameter (r=0.30, p=0.0006), indexed LA volume (r=0.51, p,0.0001), E/Ea ratio (r=0.33, p,0.0001), systolic pulmonary pressure (r=0.24, p=0.006) and GLS (r=-0.54, p,0.0001). On multiple regression analysis, only indexed LA volume and GLS were independently associated with BNP (b=1.1+0.4, p=0.002 and b=6.6+1.4, p,0.001, respectively). During follow-up (mean=23+19 months), 54 events occurred resulting in a 4-year cardiac event-free survival=50+6%. According to the median of BNP, patients with high BNP level had significant reduced eventfree survival (21+8% vs. 75+6%, p,0.0001). A GLS,23% was also associated with a lower event-free survival (85+6% vs. 33+7%, p,0.0001). In Cox multivariate analysis, after adjustment for age, sex, E/Ea ratio and indexed end-systolic diameter, only indexed LA volume (hazard ratio [HR]=1.01, 95% confidence interval [CI]: 1.01.3, p=0.036), GLS,23% (HR=3.3, 95%CI: 1.1-9.9, p=0.03) and BNP,41pg/ml (HR=3.5, 95%CI: 1.7-7.2, p=0.001) were independent determinants of cardiac eventfree survival. In addition, compared to the first quartile of BNP (,19pg/ml), second (19-41pg/ml), third (42-70pg/ml) and fourth (71-439pg/ml) quartiles of BNP were associated with a 3.5-, 10and 11-fold increase in risk of cardiac events (p=0.06, p,0.0001 and p,0.0001, respectively). Conclusion: In asymptomatic degenerative MR, LV longitudinal function and LA volume are the main determinants of BNP release. BNP is a powerful independent predictor of cardiac events. Assessment of plasma BNP level, LA volume, and LV longitudinal function may help to improve risk stratification and the management of these patients. |
| File Format | PDF HTM / HTML |
| DOI | 10.1093/ejechocard/jer200 |
| Volume Number | 12 |
| Alternate Webpage(s) | https://academic.oup.com/ehjcimaging/article-pdf/12/suppl_2/ii1/7116765/jer200.pdf |
| Alternate Webpage(s) | https://doi.org/10.1093/ejechocard%2Fjer200 |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
